Weight loss can be a challenge, even for those who eat healthily and exercise regularly. But injectable type 2 diabetes ...

"Since more than half of U.S. adults who have taken GLP-1 receptor agonists state the therapy was difficult to afford, ...

A manufacturer-funded study found a significant decrease in annual total medical costs in patients with overweight/obesity ...

Once-weekly semaglutide shows significant reduction in knee osteoarthritis pain and body weight in adults with obesity, a ...

Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...

The maximum recommended dose is 1 mg per week. • Semaglutide injection is administered by subcutaneously (just under the skin) of the upper arm, abdomen or thigh once in a week. • The ...